✦ LIBER ✦

Short Communication: A Comparison of the Biologic Activity of Two Recombinant IFN-β Preparations Used in the Treatment of Relapsing-Remitting Multiple Sclerosis

✍ Scribed by Antonetti, Francesco; Finocchiaro, Ornella; Mascia, Michele; Terlizzese, Maria Grazia; Jaber, Amer

Book ID: 111938682
Publisher: Mary Ann Liebert
Year: 2002
Tongue: English
Weight: 120 KB
Volume: 22
Category: Article
ISSN: 1079-9907
DOI: 10.1089/10799900260475696

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Cost Effectiveness of Interfer

Long-Term Cost Effectiveness of Interferon-β-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis

✍ Claude Lepen, Patricia Coyle, Timothy Vollmer, Lance Blumhardtf, Hervé Lilliu, D 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 145 KB

Incidence of exacerbations in the first

Incidence of exacerbations in the first 90 days of treatment with recombinant human interferon β-1b in patients with relapsing-remitting multiple sclerosis

✍ Dr. Omar A. Khan; J. Richard Hebel 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 1 views

Contrasting responses to interferon β-1b

Contrasting responses to interferon β-1b treatment in relapsing-remitting multiple sclerosis: Does baseline interleukin-12p35 messenger RNA predict the efficacy of treatment?

✍ A. H. H. Van Boxel-Dezaire; S. C. J. Van Trigt-Hoff; J. Killestein; H. M. Schrij 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

A prospective, open-label treatment tria

A prospective, open-label treatment trial to compare the effect of IFN -1a (Avonex(R)), IFN -1b (Betaseron(R)), and glatiramer acetate (Copaxone(R)) on the relapse rate in relapsing-remitting multiple sclerosis: results after 18 months of therapy

✍ Khan, O. A; Tselis, A. C; Kamholz, J. A; Garbern, J. Y; Lewis, R. A; Lisak, R. P 📂 Article 📅 2001 🏛 SAGE Publications 🌐 English ⚖ 95 KB

SHORT-TERM TREATMENT OF RELAPSING REMITT

SHORT-TERM TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS PATIENTS WITH INTERFERON (IFN)-β1B TRANSIENTLY INCREASES THE BLOOD LEVELS OF INTERLEUKIN (IL)-6, IL-10 AND IFN-γ WITHOUT SIGNIFICANTLY MODIFYING THOSE OF IL-1β, IL-2, IL-4 AND TUMOUR NECROSIS FACTOR-α

✍ Ferdinando Nicoletti; Roberto Di Marco; Francesco Patti; Paola Zaccone; Maria Ri 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 109 KB

3-31-15 The effect of two different dose

3-31-15 The effect of two different doses of ricombinant interferon beta-1a on relapses and total lesion volume in relapsing-remitting multiple sclerosis over the 24 month treatment period

✍ T. Koudriavtseva; C. Pozzilli; S. Bastianello; C. Gasperini; S. Galgani; F. Bagn 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 176 KB